NSCLC (NON-SMALL CELL LUNG CANCER)
Clinical trials for NSCLC (NON-SMALL CELL LUNG CANCER) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (NON-SMALL CELL LUNG CANCER) trials appear
Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
AI-Designed vaccine takes on lung cancer in new trial
Disease control ENROLLING_BY_INVITATIONThis study tests a personalized vaccine called Microlyvaq™ for people with advanced non-small cell lung cancer. The vaccine is custom-made for each patient using AI and computer modeling to target their unique tumor. About 90 participants will receive the vaccine plus standard ch…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests an experimental drug called DECOY20, given alone or with another drug (tislelizumab), in about 120 adults with advanced solid tumors like liver, colorectal, pancreatic, lung, head and neck, bladder, or MSI-high cancers. The main goals are to check saf…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)
Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control
Last updated May 18, 2026 11:58 UTC
-
New platform aims to predict lung cancer treatment success
Knowledge-focused OngoingThis study collects tissue samples from 200 people with advanced non-small cell lung cancer to train a new diagnostic platform. The goal is to see if the platform can accurately predict how well a patient's tumor will respond to immunotherapy. Participants provide a tissue sample…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)
Sponsor: Elephas • Aim: Knowledge-focused
Last updated May 26, 2026 03:12 UTC
-
Tissue collection study aims to build smarter cancer test
Knowledge-focused OngoingThis study collects fresh tumor samples from 416 adults with various cancers (bladder, kidney, colorectal, head and neck, liver, lung, skin, endometrial) to develop and train a live tumor diagnostic platform. The goal is to see how accurately the platform can predict whether a pa…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)
Sponsor: Elephas • Aim: Knowledge-focused
Last updated May 26, 2026 03:08 UTC